case_images: PMC5290639_01
case_images: Progressive recurrent pelvic disease resulting in hydronephrosis
case_images: 40661_2017_38_Fig1_HTML.jpg
case_images: PMC5290639_01_40661_2017_38_Fig1_HTML.jpg
case_images: Fig1
case_images: Shortly thereafter, she was admitted for small bowel obstruction, with imaging revealing multifocal progression of the pelvic lesions (Fig. 1). Following cycle 2 of therapy, the patient was admitted for progressive pelvic pain due disease progression resulting in obstructive uropathy (Fig. 1).
case_images: Reduction in lesion size after starting nivolumab
case_images: 40661_2017_38_Fig2_HTML.jpg
case_images: PMC5290639_01_40661_2017_38_Fig2_HTML.jpg
case_images: Fig2
case_images: After 2 doses, radiographic imaging demonstrated a decreased in size of all target lesions (Fig. 2).
case_images: Complete resolution of all lesions after 6th dose of nivolumab
case_images: 40661_2017_38_Fig3_HTML.jpg
case_images: PMC5290639_01_40661_2017_38_Fig3_HTML.jpg
case_images: Fig3
case_images: PET/CT obtained 3 weeks after the final dose demonstrated complete resolution of all target and non-target lesions (Fig. 3).